Adverse event intensity | |
Mild | An event that is easily tolerated by the subject, causing minimal discomfort and not interfering with everyday activities |
Moderate | An event that causes sufficient discomfort as to interfere with normal everyday activities |
Severe | An event that prevents normal everyday activities |
Serious | Any untoward medical occurrence that: o Results in death o Is life threating (an event in which the subject was at risk of death at the time of the event) o Requires hospitalization or prolongation of an existing hospitalization o Results in disability or permanent damage as defined as a substantial disruption of a person’s ability to conduct normal life functions o Is a congenital anomaly/birth defect o Other adverse events that may jeopardize the subject or may require medical or surgical intervention to prevent one of the other outcomes |
Adverse event causality | |
Unrelated | Where an event is not considered related to the investigational medicinal product |
Unlikely | Although the relationship to investigational medicinal product cannot be completely ruled out, the nature of the event, the underlying disease, concomitant medication or temporal relationship make other explanations more likely |
Possibly related | The temporal relationship and the absence of a more likely explanation suggest the event could be related to the investigational medicinal product |
Probably related | The known effects of the investigational medicinal product or its therapeutic class, or based on challenge testing, suggest the investigational medicinal product is the most likely cause |
Definitely related | This category applies to those AEs that are clearly a consequence of administration of the drug. It is likely that such events will be widely documented and generally accepted as having association with the study medication. |